Higher-risk myelodysplastic syndromes with del(5q): Is sequential azacitidine-lenalidomide combination the way to go?

Amer M. Zeidan, Steven D. Gore, Rami S. Komrokji

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Higher-risk myelodysplastic syndromes with del(5q): Is sequential azacitidine-lenalidomide combination the way to go?'. Together they form a unique fingerprint.

Medicine & Life Sciences